- Home
- / Venus Remedies
Venus Remedies
Revenue
₹6.5 B
FY, 2025
Venus Remedies Summary
Company Summary
- Overview
- Venus Remedies (VRL) is a company that researches, develops, and manufactures pharmaceuticals. It offers healthcare and generic medicine, antibiotics, antimicrobial resistance breaker, oncology, research and novel drug delivery systems, fixed-dose injectables, and more.
- Type
- Public
- Status
- Active
- Founded
- 1989
- HQ
- Panchkula, IN | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Panchkula, HR HQ
India
51-52 Phase, 1, Industrial Area Phase 1
Venus Remedies Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹1.8B
- Gross profit (Q3, 2026)
- ₹965.3M
- Net income (Q3, 2026)
- ₹255.8M
- Cash (Q2, 2026)
- ₹425.9M
- EBIT (Q3, 2026)
- ₹334.8M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026